Definitions and general provisions; creating right to refuse any vaccine, medication, microchip, external tracker, or other manufactured product. Emergency.
SB 1656 would create a broad statutory right for every person to refuse any vaccine, medication, microchip, external tracker, or other manufactured product. The bill states that its purpose is to protect medical freedom, personal autonomy, and bodily privacy, and it would bar the state, political subdivisions, schools, employers, businesses, and other public or private entities from requiring those items as a condition of public services, school admission, employment, consumer goods or services, access to public accommodations, or any other privilege or right.
The bill also creates a private right of action against any person or entity that violates the prohibition or otherwise infringes the protected right. A prevailing plaintiff could recover injunctive relief, declaratory relief, compensatory and punitive damages, costs, and reasonable attorney fees. The measure contains an emergency clause, meaning it would take effect immediately upon passage and approval.
If enacted, SB 1656 would add a new section to Title 25 of the Oklahoma Statutes and significantly limit the ability of both public and private actors to impose mandates involving vaccines, medications, microchips, external trackers, or similar manufactured products. It would expose violators to civil liability and authorize courts to award broad remedies, including damages and attorney fees, which could affect employers, schools, businesses, healthcare-related policies, and government service requirements across the state.
The available record shows no committee transcript or recorded votes, so there is no direct evidence of debate or formal support/opposition in the materials provided. Based on the bill text, the measure is framed in strongly rights-protective terms, emphasizing medical freedom and privacy, which suggests it is intended to appeal to supporters of bodily autonomy and anti-mandate positions.
The main points of contention are likely to be the bill’s very broad scope and its application to both public and private entities. Supporters would likely view it as a safeguard against coercive mandates and invasive tracking, while opponents may argue it could interfere with public health measures, workplace policies, school requirements, and business discretion. The inclusion of microchips, external trackers, and “any other manufactured product” makes the bill especially expansive and potentially difficult to interpret or apply.